Decentralized Clinical Trial (DCT)
A clinical trial utilizing technology, processes, and/or services that create the opportunity to reduce or eliminate the need for participants to physically visit a traditional research site.
Source: Decentralized Trials and Research Alliance (DTRA)
How can incorporating decentralized clinical trial (DCT) attributes in clinical trials benefit patient enrollment and retention, increase diversity in trial sets, and potentially lead to better outcomes, especially for those facing travel or mobility barriers?
Speak to a specialist
Download our Infographic
Download Trialtrove’s data-rich infographic, “Unlocking the Potential of Decentralized Clinical Trials” to uncover trends in trials using DCT attributes over the past several years.
Download now
Download our White paper
Download our whitepaper to discover emerging trends and challenges to implementing Decentralized Clinical Trial models with expert analysis and exclusive proprietary data from Citeline’s Trialtrove.
Download nowAbout the Authors
Anna Osborne
Anna is a Managing Consultant in the Citeline/Evaluate Consulting and Analytics team, a team which specializes in pharmaceutical and healthcare consultancy. Within her role Anna answers key asset, portfolio, and corporate strategy-related business questions.
Prior to joining the Consulting and Analytics team, Anna was an analyst at Citeline’s Pharmaprojects. Here, she expertly curated the drug development database, provided research support to clients and produced custom analytics projects, transforming clinical study data and drug data into actionable insights.
Susan Danheiser
Susan has been with Citeline since 2004, where she has assumed various roles including early development of Trialtrove’s oncology content, managing Citeline’s custom analytics/consulting services, and driving key product enhancements.
She currently serves as Trialtrove Director for the CNS, Autoimmune/Inflammation and Ophthalmology therapeutic areas.
Trialtrove's new Decentralized Clinical Trial Attribute filter
With Citeline Trialtrove's new Decentralized Attribute filter you can stay strategically aligned with developments across a wide range of diseases, companies, drugs, and trends.
If you want to learn more about this enhancement, and how to design the most successful clinical trials, request a demo today!
Request a demoDid you enjoy our whitepaper?
Read more about Citeline and Evaluate Consulting & Analytics
Harnessing the combined capabilities of Citeline and Evaluate, the Consulting & Analytics group works directly with clients on bespoke engagements that share Norstella’s vision of smoothing the path to life-saving treatment, from pipeline to patient.
Our team consists of nearly 100 consultants globally, supported by extensive proprietary data assets and experience across therapeutic areas and modalities. We specialize in the areas of asset and portfolio strategy, licensing and transaction advisory, competitive intelligence, clinical strategy and planning, and global market access.
Speak with our team
Citeline is now a proud member of the DTRA: Decentralized Trials & Research Alliance, dedicated to making research participation accessible to all.
More details coming soon!